Canaccord analyst Caitlin Cronin downgraded Paragon 28 (FNA) to Hold from Buy with a price target of $13, down from $15, after Zimmer Biomet (ZBH) agreed to acquire the company for $13 in cash per share plus up $1 per share in a contingent value right.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FNA: